Phocas Financial Corp. Apellis Pharmaceuticals, Inc. Transaction History
Phocas Financial Corp.
- $695 Billion
- Q2 2025
A detailed history of Phocas Financial Corp. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Phocas Financial Corp. holds 71,599 shares of APLS stock, worth $1.74 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
71,599Holding current value
$1.74 Million% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
295Shares Held
132MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$298 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$290 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$247 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$238 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$219 Million0.03% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.68B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...